Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

CTX granted for phase IIa trial of ATL-104 for mucositis

Jan. 5, 2004

First patient enrolled in trial of dendritic cell vaccine for melanoma

Jan. 5, 2004

Tributyrin induces apoptosis of leukemia cell lines

Dec. 30, 2003

Potential clinical benefits of CAI in ovarian cancer

Dec. 30, 2003

European orphan drug designation for gimatecan for glioma

Dec. 30, 2003

Enrollment completed in phase IIa study of PCK-3145

Dec. 30, 2003

GTI-2501 enters phase II

Dec. 30, 2003

CPMP rejects PharmaMar appeal regarding Yondelis

Dec. 30, 2003

Novacea stops enrollment in DN-101 trial for MDS

Dec. 30, 2003

Clinical effects of tipifarnib in hematological malignancies

Dec. 29, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...